Skip to content

Persona Versus NexGen

Migration and Kinematics of the New Persona PS Versus the Proven NexGen LPS Knee - a Randomized Controlled Trial Using Radiostereometric Analysis and Fluoroscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02269254
Enrollment
75
Registered
2014-10-21
Start date
2014-09-30
Completion date
2019-06-30
Last updated
2020-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Joint Diseases, Musculoskeletal Diseases, Osteoarthritis Arthritis, Rheumatic Diseases

Keywords

Comparative Study, Knee Prosthesis, Prosthesis Design, Treatment Outcome, Follow-Up Studies, Arthroplasty, Replacement, Knee/methods

Brief summary

The NexGen TKR (Zimmer, Warsaw, Indiana, USA) is a proven TKR design that has reported excellent medium and long-term results in clinical studies and in implant registries all around the world. As a follow-up of the NexGen TKR, an improved design has recently been introduced by Zimmer: The Persona TKR (Zimmer, Warsaw, Indiana, USA) has been used successfully in about 20.000 patients, but results from independent clinical studies have not been reported yet. The objective of this study is to accurately assess and compare migration, kinematics, prosthesis placement and patient reported outcomes of two TKR prostheses: the fixed bearing, cemented NexGen LPS, a proven design with an excellent clinical track record, and the fixed bearing, cemented Persona PS, a new design without clinical data (both designs by Zimmer, Warsaw, Indiana, USA). The primary objective is to assess and compare migration of the two TKR prostheses (Femoral and Tibial component). The secondary objective is to assess and compare clinical data, kinematics, prosthesis placement and patient reported outcome measures. This study is designed as a single-blind randomized trial between the Persona PS total knee prosthesis and the well-established NexGen total knee prosthesis. Different sample sizes are used for the different parts of this study: * 30 Patients with NexGen LPS prosthesis and 30 patients with Persona PS prosthesis for RSA * 15 Patients with NexGen LPS prosthesis and 15 patients with Persona PS prosthesis for Fluo The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for TKR surgery at the Department of Orthopaedics, Leiden University Medical Center. Annually 40 TKA procedures are performed in our department, of which about 70% is Osteo Arthritis (OA) and 30% Reumatoid Arthritis (RA). We anticipate that inclusion can be accomplished within a 2 year period. Main study parameters/endpoints are: * Migration, measured by means of RSA. * Prosthesis placement and bone resection measured by means of CT and caliper measurements of the resected bone parts. * In vivo kinematics by means of fluoroscopy. * Patient Reported Outcome Measures by means of questionaires.

Interventions

DEVICEPersona PS Knee Prosthesis by Zimmer

Total Knee Replacement with Persona PS Knee Prosthesis by Zimmer

DEVICENexGen PS Knee Prosthesis by Zimmer

Total Knee Replacement with NexGen PS Knee Prosthesis by Zimmer

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
Leiden University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
21 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patient is diagnosed with osteoarthritis or rheumatoid arthritis and requiring primary knee arthroplasty * Patient has been classified ASA 1 or 2 (for the kinematic analysis) (Meyer Saklad, 1941). As for the RSA study all consecutive patients (usual care) are included to prevent selection bias in the migration analysis. Stratification is performed per diagnosis group (OA/RA).

Exclusion criteria

* The patient is unable or unwilling to sign the Informed Consent specific to this study * Insufficient Dutch or English language skills * Patients indicated for revision arthroplasty * Patient is (or might be) pregnant * When there are less than five tibia-bone markers and less than five femur-bone markers visible in the baseline RSA photograph and it will not improve by placing the patient in another position, the patient will be excluded from the study (secondary

Design outcomes

Primary

MeasureTime frameDescription
Migration, measured by means of RSA.2 YearsMigration (MTPM in mm) of the prosthesis with respect to the host bone measured by means of roentgen stereophotogrammetric analysis (RSA).

Secondary

MeasureTime frameDescription
Knee Prosthesis motion by means of Fluoroscopy.1 YearMotion of the knee prosthesis during a step-up movement, measured by means of Fluoroscopic Motion Analysis.
EQ-5D2 YearsGeneral Health: EuroQol 5 Dimensional (EQ-5D) Health Questionnaire measured using patient questionnaire
KOOS2 YearsKnee Function: Knee injury and Osteoarthritis Outcome Score (KOOS) measured using patient questionnaire
VAS pain2 YearsPain score after activity and during rest; (Likert scale 0-10)

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026